AKBA
Akebia Therapeut (AKBA)
NASDAQ
$0.86-$0.01 (-1.15%)
Price as of Oct 02, 2026 6:03 PM EDT
  • $241.4M
    Market Cap
  • -67.86%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 62
Valuation
AKBA
vs History
vs S&P 500
Profitability
1
Growth
1
Low Earnings Volatility
1

Momentum Score

Score: 22
Valuation
AKBA
vs History
vs S&P 500
3-Month Momentum
-17.13%
12-Month Momentum
-64.75%
3-Month Risk Adjusted Momentum
-48.25%
12-Month Risk Adjusted Momentum
-84.72%

True Yield

N/A
Valuation
AKBA
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
-0.13%

Financial Health Score

Score: 85
Valuation
AKBA
vs History
vs S&P 500
Ohlson's O-Score
7